Nyra Medical
Nyra Medical is a structural heart company focused on developing a first in class transcatheter valve repair technology.
Nyra Medical is a structural heart company focused on developing a first in class transcatheter valve repair technology.
Nyra Medical is a structural heart company focused on developing a first in class transcatheter valve repair technology. Based in Atlanta, US, the company was founded in 2018. Nyra Medical's primary goal is to correct leaky heart valves by enhancing the contour of the native leaflet with an implant. The company recently received a significant $20.00M Series A investment on 18 November 2022, from notable investors including Broadview Ventures, Epidarex Capital, Georgia Research Alliance Venture Fund, and Vensana Capital. This investment demonstrates the confidence and support of key players in the industry, indicating the potential for Nyra Medical's innovative technology to make a significant impact in the structural heart space.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $20.00M | 4 |
|
18 Nov 2022 |
| Grant | $56.76K | 1 |
|
21 Jan 2020 |
| Grant | $74.94K | 1 |
|
26 Sep 2016 |
| Grant | $20.00K | 1 |
|
27 Apr 2016 |
| Grant | $52.30K | 1 |
|
14 Jul 2014 |
No recent news or press coverage available for Nyra Medical.
We care about your data, and we'd love to use cookies make your experience better.
